Email:
Phone:

Get A Quote

Inquiry

Lipid-Hyaluronic Acid Conjugation

Name: Lipid-Hyaluronic Acid Conjugation
Brand: BOC Sciences

Lipid-hyaluronic acid conjugation is an advanced chemical modification technique that combines natural polysaccharides with lipid molecules. Hyaluronic Acid (HA) is a naturally occurring high-molecular-weight polysaccharide widely present in human tissues, known for its excellent biocompatibility, biodegradability, and hydration properties. Lipids are essential components of cell membranes and are commonly used to construct liposomes or lipid nanoparticles. Covalently linking lipids to HA imparts new physicochemical properties to HA, expanding its potential applications in drug delivery, cosmetics, and tissue engineering. BOC Sciences offers professional lipid-HA conjugation services, leveraging extensive lipid chemistry expertise and advanced experimental platforms to support full-process R&D from molecular design and chemical conjugation to nanocarrier construction. We provide customized lipid types, HA molecular weights, and functional modifications, offering efficient conjugation, nanoparticle self-assembly, and comprehensive characterization services to ensure product quality, stability, and functionality.

Unlock High-Quality Lipid–Hyaluronic Acid Conjugates

BOC Sciences is committed to providing diverse lipid-HA conjugates to meet various research and application needs. Using professional chemical conjugation techniques and customized strategies, we develop high-quality, functionalized lipid-HA conjugates for drug delivery, gene carriers, cosmetics, and tissue engineering. The main types of lipid-HA conjugates and service capabilities we offer include:

Fatty Acid-HA Conjugates Supports various fatty acids such as palmitic acid, stearic acid, and oleic acid to modulate hydrophilic/hydrophobic balance and self-assembly properties. Achieves high conjugation efficiency through amidation or click chemistry, with adjustable lipid loading ratios. Supports self-assembly into micelles, nanoparticles, or nanogels for hydrophobic drug encapsulation or active ingredient delivery.
Phospholipid-HA Conjugates Offers phospholipid options including phosphatidylcholine (PC) and phosphatidylethanolamine (PE) to suit different nanocarrier systems. Employs amidation or click chemistry conjugation to meet various structural and functional requirements. Supports integration with liposomes or self-assembly into lipid nanoparticles for drug and gene delivery.
Cholesterol-HA Conjugates Enhances nanoparticle membrane rigidity and in vivo circulation stability via cholesterol modification. Enables additional functionalities such as drug loading, targeting modifications, or fluorescent labeling. Supports construction of stable liposomes or self-assembled nanoparticles suitable for controlled drug release.
HA-Conjugated Liposome Nanoparticles Selects HA with appropriate molecular weight and modification based on client requirements. Constructs liposomes using high-quality lipids such as phospholipids and cholesterol. Modifies HA onto the liposome surface via chemical crosslinking or physical adsorption.

Looking for Custom Lipid-Hyaluronic Acid Conjugates?

Whether you need small molecule, nucleic acid, peptide, or protein conjugates, our experts can design and deliver optimized solutions for your project.

Contact Our Lipid Specialists Today!

High-Efficiency Lipid-Hyaluronic Acid Conjugation Services

We offer comprehensive lipid-HA conjugation services covering the full process from molecular design to nanocarrier construction. Utilizing efficient chemical conjugation techniques and specialized characterization methods, we provide customized solutions for drug delivery, gene therapy, cosmetics, and tissue engineering. Our services help clients achieve high-quality, stable, and functional lipid-HA conjugates, accelerating research and development.

Lipid Selection and Molecular Design Provides fatty acids, phospholipids, cholesterol, and multifunctional lipid options. Designs lipid chain length, saturation, and chemical modifications according to client needs. Allows incorporation of targeting ligands, fluorescent labels, or responsive groups for multifunctional applications.
Hyaluronic Acid Modification and Activation Selects HA with suitable molecular weight to meet specific application requirements. Activates carboxyl or hydroxyl groups to provide high-reactivity sites for conjugation. Preserves HA's natural bioactivity to ensure targeting and biocompatibility.
Chemical Conjugation Preparation Offers amidation, esterification, and click chemistry conjugation strategies. Controls reaction conditions to achieve high conjugation efficiency and tunable lipid loading. Supports customized conjugation sites for both research and industrial applications.
Nanoparticle Construction and Self-Assembly Self-assembles lipid-HA conjugates into nanoparticles, micelles, or liposomes. Controls particle size, surface charge, and drug loading to suit various delivery strategies. Provides optimization for drug encapsulation, release profiles, and stability.
Characterization and Quality Control Confirms structure via NMR, FTIR, and mass spectrometry. Evaluates nanoparticle properties using dynamic light scattering (DLS) and ζ-potential measurements. Delivers complete data reports on conjugation efficiency, stability, and reproducibility.
Functionalization and Targeting Optimization Enables the design of CD44-targeted, pH-responsive, or enzyme-responsive lipid–HA conjugates. Achieves targeted drug delivery, controlled release, and microenvironment-responsive functions. Supports multifunctional composite designs suitable for combination therapy or imaging applications.

Interested in Our Lipid Conjugation Services?

Get in touch with our experts today! We'll respond within 24 hours to discuss your project needs and provide a customized quote.

Submit Your Request Now!

Why Choose BOC Sciences: Key Advantages You Can Trust

Extensive Lipid Selection: Offers fatty acids, phospholipids, cholesterol, and multifunctional lipids to meet diverse applications in drug delivery, cosmetics, and tissue engineering, enabling personalized customization.
Efficient Conjugation Technology: Utilizes amidation, esterification, and click chemistry to achieve high conjugation efficiency, preserving HA bioactivity while precisely controlling lipid loading ratios.
Nanocarrier Construction Capability: Self-assembles lipid-HA conjugates into nanoparticles, micelles, or liposomes, ensuring stable drug encapsulation and controlled release, optimizing in vivo delivery performance.
Comprehensive Characterization: Provides NMR, FTIR, mass spectrometry, particle size, and ζ-potential analyses to ensure accurate structure and controllable properties of lipid-HA conjugates.
Customized R&D Support: Offers full-process services from molecular design and conjugation preparation to nanocarrier construction, accommodating both research and industrial-scale development needs.
Technical Optimization and Problem Solving: Provides strategies to improve conjugation efficiency, stability, and nanoparticle assembly, addressing technical challenges quickly to enhance development efficiency.
Advanced Experimental Facility Support: Equipped with high-precision reactors, clean benches, analytical instruments, and nanoparticle preparation equipment, providing reliable experimental assurance for lipid-HA conjugation.

Lipid-Hyaluronic Acid Conjugation Service Workflow

Our expert team leverages extensive lipid chemistry experience and advanced experimental platforms to ensure each step is efficient and controlled, delivering reliable R&D support and high-quality products.

Requirement Communication and Project Design Engage with clients to discuss project goals, including drug delivery type, targeting requirements, and application scenarios. Provide professional recommendations on lipid selection, HA molecular weight, conjugation strategies, and functional modifications. Develop personalized R&D plans to ensure experimental feasibility and that final performance meets expectations.
Raw Material Preparation and Activation Select high-purity lipids and HA to ensure stability and reactivity. Activate HA carboxyl or hydroxyl groups to provide high-reactivity sites for conjugation. Control reaction conditions to minimize side reactions and maintain conjugate integrity.
Conjugation Reaction Preparation Perform covalent linkage using amidation, esterification, or click chemistry. Precisely control temperature, pH, and reaction time for high conjugation efficiency and uniform product distribution. Preserve HA bioactivity while adjusting lipid loading to meet functional requirements.
Purification and Separation Remove unreacted materials and byproducts using dialysis, ultrafiltration, or chromatography. Ensure high-purity, reusable lipid-HA conjugates. Provide purity and stability analysis to meet research or industrial standards.
Nanoparticle Construction and Self-Assembly (Optional) Self-assemble lipid-HA conjugates into nanoparticles, micelles, or liposomes, controlling size and surface characteristics. Optimize drug loading and release rate based on drug properties for controlled and targeted delivery. Support multifunctional design such as CD44 targeting, pH responsiveness, or enzyme-triggered release for advanced carrier functionality.
Characterization and Performance Optimization Provide comprehensive analyses including NMR, FTIR, mass spectrometry, particle size distribution, ζ-potential, and conjugation rate. Optimize conjugation conditions and nanoparticle assembly based on characterization results. Ensure stable, reproducible conjugates suitable for research and preclinical applications.

Interested in Our Custom Lipid Solutions?

Contact our lipid chemistry experts to discuss your project needs.

Request a Free Consultation!

Applications of Lipid-Hyaluronic Acid Conjugates

Lipid-HA conjugates, with their unique amphiphilic structures and biocompatibility, are widely applied in cancer therapy, drug delivery, gene therapy, cosmetics, and tissue engineering. Combining lipids with HA enhances carrier stability, targeting, and controlled release, providing reliable solutions for research and industrial development.

Drug Delivery Self-assembles into nanoparticles or micelles for hydrophobic drug encapsulation. HA targets CD44 receptors for precise delivery to tumors or specific tissues. Drug release rates can be controlled by adjusting lipid loading and HA molecular weight.
Gene Therapy and Nucleic Acid Delivery Delivers siRNA, mRNA, or DNA to improve cellular uptake efficiency. HA provides biocompatibility and targeting, reducing immune responses and cytotoxicity. Designs pH-responsive or enzyme-sensitive systems for smart release and targeted expression.
Cosmetics and Skin Care Enhances HA skin penetration for deep hydration and anti-wrinkle effects. Forms nanoemulsions or microcapsules to improve active ingredient absorption. Used in anti-aging, moisturizing, and skin barrier repair products.
Tissue Engineering and Regenerative Medicine Constructs hydrogels or 3D scaffolds mimicking the extracellular matrix. Supports cell adhesion, proliferation, and migration to promote tissue repair and regeneration. Tunes mechanical properties and degradation rates for customized scaffold design.

Frequently Asked Questions

Still have questions?

What is lipid-hyaluronic acid conjugation?
Lipid-hyaluronic acid (HA) conjugation involves chemically attaching lipid molecules to HA chains, forming amphiphilic compounds. This modification enhances self-assembly, improves drug encapsulation, and increases stability in biological systems, making it suitable for advanced drug delivery and biomaterial applications.
What are the main applications of lipid-HA conjugates?
Lipid-HA conjugates are widely used in targeted drug delivery, nanocarrier systems, cosmetics, and tissue engineering. By combining the bioadhesive properties of HA with lipid-induced membrane interaction, these conjugates improve bioavailability, enhance cellular uptake, and enable controlled release of therapeutic agents.
What are the advantages of lipid-HA conjugates?
These conjugates combine HA's biocompatibility with lipid-mediated membrane fusion. They enhance carrier stability, prolong circulation time, reduce systemic toxicity, and enable targeted delivery. Their amphiphilic nature also facilitates self-assembly into micelles or nanoparticles, improving solubility and drug encapsulation efficiency.
What conjugation methods are commonly used?
Common methods include carbodiimide-mediated coupling (EDC/NHS), activated ester reactions, and click chemistry. The choice depends on the lipid structure, HA molecular weight, and application requirements. Efficient conjugation ensures reproducible self-assembly and functional performance of the resulting nanocarriers or biomaterials.
How is the conjugated product characterized?
Characterization typically involves NMR, mass spectrometry (MS), FTIR spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM). These techniques confirm chemical structure, degree of conjugation, particle size, morphology, and uniformity, ensuring quality control for research or pharmaceutical applications.
How stable are lipid-HA conjugates?
Stability depends on lipid type, HA molecular weight, conjugation efficiency, and storage conditions. Under appropriate pH, temperature, and buffer conditions, conjugates can maintain structural integrity and functional performance for extended periods, making them suitable for long-term pharmaceutical or cosmetic use.
How to choose the right lipid and HA combination?
Selection depends on drug properties, delivery route, and target tissue. Lipid type (e.g., phospholipids, cholesterol derivatives) and HA molecular weight must be optimized to maximize conjugation efficiency, self-assembly, and biological performance, ensuring effective encapsulation and targeted delivery of therapeutics.

Case Studies and Success Stories

Background

A European oncology startup aimed to develop a local delivery platform based on HA-modified lipid nanoparticles (HA-LNPs) to target CD44-overexpressing solid tumor cells. However, commercially available HA–lipid conjugates were limited, and in-house preparations often suffered from inconsistent conjugation efficiency, poor batch reproducibility, and HA molecular weight degradation. These issues led to significant variability in nanoparticle size, encapsulation efficiency, and in vivo performance. To improve material quality and systematically compare the effects of different lipid structures (DSPE, DMPE, cholesterol) on HA-LNP performance, the company sought high-purity, controllable, and fully characterized HA–lipid conjugates from BOC Sciences.

What Does BOC Sciences Do?

BOC Sciences' lipid chemistry and polysaccharide conjugation team provided a complete technical solution from reaction design and custom synthesis to structural verification:

Designing tailored conjugation routes based on lipid properties: DSPE used EDC/NHS activation to form stable amide bonds; DMPE conjugation optimized pH and solvent systems for uniformity; Cholesterol was hydroxyl-activated to form carbonate bonds, ensuring proper membrane embedding.
Verifying structural integrity and degree of substitution (DS) with multidimensional analysis: ¹H NMR, GPC, HPLC, LC–MS confirmed lipid insertion ratios, HA backbone preservation, and stable DS ranges.
Evaluating compatibility in nanoparticle systems: Compared DSPE-HA, DMPE-HA, and Cholesterol-HA for particle size, PDI, zeta potential, membrane stability, and cellular uptake potential, providing data to guide formulation selection.

Key Outcomes

Successfully prepared three high-purity, controllable DS HA–lipid conjugates (DSPE-HA, DMPE-HA, Cholesterol-HA) with excellent batch consistency.
Enhanced tumor cell targeting: DSPE-HA particles showed ~3-fold increased uptake in CD44⁺ tumor cells.
Improved nanoparticle stability: Cholesterol-HA exhibited lower PDI, higher drug loading, and superior storage stability.
Significantly reduced formulation development risks, enabling rapid progression to in vivo pharmacokinetics and efficacy studies.

Background

A biomaterials company in Hamburg, Germany, was developing long-circulating nanocarriers for intra-articular administration and chronic inflammation therapy. They aimed to leverage HA targeting to CD44 on inflammatory cells, combine PEG for protein resistance and prolonged retention, and incorporate lipids to enhance self-assembly and drug encapsulation. However, in constructing HA–PEG–lipid ternary structures in-house, they faced challenges including HA backbone degradation during conjugation, PEG molecular weight and functional group impacts on reaction control, and differing activation conditions for DSPE and cholesterol, complicating stable ternary formation. To obtain structurally defined, highly uniform, and scalable HA–PEG–lipid conjugates, they partnered with BOC Sciences.

What Does BOC Sciences Do?

BOC Sciences' polysaccharide chemistry, PEG derivatization, and lipid conjugation team designed a stepwise, controllable ternary conjugation strategy and provided end-to-end R&D support:

Stepwise modular conjugation: PEG–lipid first, then PEG–HA approach under mild conditions to prevent HA degradation and ensure structural control.
Precise PEG control: Selected PEG 2–10 kDa with NH₂, Mal, or N₃ end groups to achieve optimal spatial configuration and biocompatibility according to solubility, circulation time, and stability requirements.
Multidimensional structural validation: ¹H NMR, GPC, HPLC, LC–MS, FTIR confirmed PEG-lipid coupling efficiency, HA backbone preservation, DS, and material purity.
Comparing lipid modules: Evaluated DSPE and cholesterol effects on particle size, PDI, zeta potential, self-assembly, and inflammatory microenvironment stability to guide optimal lipid selection.

Key Outcomes

Successfully prepared three structurally defined, highly uniform HA–PEG–lipid conjugates with different PEG lengths and DSPE/cholesterol lipid types.
PEG modification reduced plasma protein adsorption, extending intra-articular retention 2–3 fold and improving overall stability.
HA–PEG–DSPE particles exhibited enhanced CD44-dependent uptake in macrophages and inflammatory fibroblasts, improving targeting efficiency.
HA–PEG–cholesterol demonstrated stronger hydrophobic drug encapsulation, lower PDI (<0.12), and superior storage stability.

Publications

Our publications section highlights global customers' research using BOC Sciences' lipid products and custom services in high-impact journals, demonstrating product reliability and broad applicability.

Development and validation of rapid and simultaneous method for determination of 12 hair-growth compounds in adulterated products by UHPLC–MS/MS. Forensic science international 284 (2018): 129-135. PMID: 29408720 DOI: 10.1016/j.forsciint.2017.12.042.
Hopanoids, like sterols, modulate dynamics, compaction, phase segregation and permeability of membranes. Biochimica et Biophysica Acta (BBA)-Biomembranes (2019): 183060. DOI: 10.1016/j.bbamem.2019.183060.
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren's Syndrome. Pharmaceutics 14.9 (2022): 1895. PMID: 36145642 DOI: 10.3390/pharmaceutics14091895.
Osteogenic effects of rapamycin on bone marrow mesenchymal stem cells via inducing autophagy. Journal of Orthopaedic Surgery and Research 18.1 (2023): 129. PMID: 36814286 DOI: 10.1186/s13018-023-03616-9.
Liquid chromatography–tandem mass spectrometry method for the analysis of N-(3-aminopropyl)-N-dodecylpropane-1, 3-diamine, a biocidal disinfectant, in dairy products. Food chemistry 262 (2018): 168-177. DOI: 10.1016/j.foodchem.2018.04.080.

More Publications

Client Testimonials

Industry Distribution of Custom Lipid Synthesis Clients

"BOC Sciences transformed the pace of our nanoparticle program. Their custom HA–lipid conjugates showed outstanding purity and batch-to-batch reliability—far better than anything we sourced previously. Their team truly understands the demands of translational research."
— Dr. Michael Turner, Senior Scientist (United States)
"Our project required several HA–DSPE and HA–cholesterol conjugates on a tight schedule. BOC Sciences delivered every batch exactly as promised, complete with clean analytical data and excellent technical support. Their materials helped us rapidly advance into in vivo testing."
— Ms. Emily Carter, Formulation Development Manager (United Kingdom)

"We approached BOC Sciences after multiple failed attempts to prepare HA–lipid conjugates in-house. Their experts quickly identified the bottlenecks and provided high-performance HA–PEG–lipid conjugates that dramatically improved the stability of our delivery system. A genuinely reliable partner."
— Dr. Lukas Steiner, Principal Researcher (Germany)
"From communication to production quality, BOC Sciences exceeded our expectations. The HA–lipid variants they delivered allowed us to streamline our screening workflow and uncover a lead formulation much faster than anticipated. Their expertise made a visible difference in our project timeline."
— Ms. Olivia Martin, R&D Project Lead (France)

Custom Lipid Conjugation Made Easy — Request A Quote, Available 24/7.